Hong T - Search Results

1

Injections in the back of the eye: The why, the what and when to worry.

Broadhead GK, Hong T, Chang AA. Broadhead GK, et al. Among authors: hong t. Aust J Gen Pract. 2024 Jul;53(7):476-479. doi: 10.31128/AJGP-08-23-6944. Aust J Gen Pract. 2024. PMID: 38957063 Free article.

2

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, Zhu M. Chang AA, et al. Among authors: hong t. Ophthalmology. 2014 Jan;121(1):188-192. doi: 10.1016/j.ophtha.2013.08.035. Epub 2013 Oct 18. Ophthalmology. 2014. PMID: 24144450 Clinical Trial.

3

Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

Broadhead GK, Hong T, Chang AA. Broadhead GK, et al. Among authors: hong t. Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Acta Ophthalmol. 2014. PMID: 24925048 Free article. Review.

4

The role of aflibercept in the management of diabetic macular edema.

Chang AA, Hong T, Ewe SY, Bahrami B, Broadhead GK. Chang AA, et al. Among authors: hong t. Drug Des Devel Ther. 2015 Aug 6;9:4389-96. doi: 10.2147/DDDT.S62778. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273198 Free PMC article. Review.

5

Zhu M, Wijeyakumar W, Syed AR, Joachim N, Hong T, Broadhead GK, Li H, Luo K, Chang A. Zhu M, et al. Among authors: hong t. Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):475-484. doi: 10.1007/s00417-016-3477-9. Epub 2016 Aug 30. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27572301 Clinical Trial.

6

Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes.

Chew JK, Zhu M, Broadhead GK, Luo K, Hong T, Chang AA. Chew JK, et al. Among authors: hong t. Ophthalmologica. 2017;238(1-2):23-30. doi: 10.1159/000469652. Epub 2017 Apr 11. Ophthalmologica. 2017. PMID: 28395293

7

Anti-VEGF Therapy for Diabetic Eye Diseases.

Bahrami B, Hong T, Gilles MC, Chang A. Bahrami B, et al. Among authors: hong t. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):535-545. doi: 10.22608/APO.2017350. Epub 2017 Oct 26. Asia Pac J Ophthalmol (Phila). 2017. PMID: 29076303 Free article. Review.

8

AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.

Bahrami B, Hong T, Schlub TE, Chang AA. Bahrami B, et al. Among authors: hong t. Retina. 2019 Jan;39(1):61-68. doi: 10.1097/IAE.0000000000002253. Retina. 2019. PMID: 30015767 Clinical Trial.

9

Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial.

Broadhead GK, Grigg JR, McCluskey P, Hong T, Schlub TE, Chang AA. Broadhead GK, et al. Among authors: hong t. Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):31-40. doi: 10.1007/s00417-018-4163-x. Epub 2018 Oct 20. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30343354 Clinical Trial.

10

Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration.

Spooner K, Hong T, Nair R, Chow NCC, Broadhead GK, Wijeyakumar W, Chang AA. Spooner K, et al. Among authors: hong t. Acta Ophthalmol. 2019 Aug;97(5):e706-e712. doi: 10.1111/aos.14046. Epub 2019 Feb 11. Acta Ophthalmol. 2019. PMID: 30740921 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,350 results

Search Page

Filters